DNM1L and atrial fibrillation: The NAC + AF treated group showed a significant reversion of dynamic protein changes (Figure 9A,B), mitochondrial number (Figure 9C), and fragmentation percentage (Figure 9E), as well as less DRP1 immunostaining in cardiomyocytes (Figure 9H).